Type 1 Diabetes Trial, Recruiting NCT07638345 Sponsor: Adhera Health, Inc. Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT07638345
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are actively involved in caring for a young person aged 12 to 21 who has been diagnosed with Type 1 Diabetes or asthma
  • The young person in their care must fall into one of these groups: has Type 1 Diabetes and a healthy weight, has Type 1 Diabetes and is overweight or obese, or has asthma and is overweight or obese (weight categories are based on standard growth chart percentiles — confirm with trial site if unsure which applies)
  • Caregivers who are willing to take part in a digital health program called the Adhera Caring Digital Program-Obesity (ACDP-O)
  • Caregivers who have access to a smartphone or internet-connected device that works with the study's app
  • Caregivers who are willing to provide self-reported health information about the young person in their care, including details about their condition and physical measurements
  • For caregivers of young people with Type 1 Diabetes, a willingness to share continuous glucose monitoring (CGM) data from the young person's diabetes device

Who may not be able to join:

  • Caregivers who have severe mental health or cognitive difficulties that would make it hard to take part in a digital program
  • Caregivers who are currently enrolled in another digital health study related to obesity or a chronic illness
  • Caregivers who are unable or unwilling to follow the study's required procedures
  • Caregivers who are unable or unwilling to provide formal consent to participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +1 (831) 345-5357

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Adhera Health, Inc.
Registry
ClinicalTrials.gov
Start date
30 October 2025
Est. completion
27 March 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Feasibility of the ACDP-O Intervention; Acceptability of the ACDP-O Intervention; Change in Mental Well-being (DASS-21); Change in Family Well-being; Change in Quality of Life (Distress); Change Quality of Life (KIDSCREEN-10)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov